Home › Funds › Empyrean Capital Partners, LP › BTI
Empyrean Capital Partners, LP position in BTI
BRITISH AMERN TOB PLC · Health Care
Empyrean Capital Partners, LP reported holding 1,925,000 shares of BTI (BRITISH AMERN TOB PLC) in its Q2 2026 13F filing — a position valued at US$118.9M, representing 3.93% of its reported portfolio and ranking #3 among its reported holdings. Empyrean Capital Partners, LP has disclosed BTI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Empyrean Capital Partners, LP's BTI position evolved
Empyrean Capital Partners, LP first disclosed a stake in BTI in Q2 2025 at 950,000 shares (US$45.0M). The position peaked in Q4 2025 at 2,200,000 shares, worth US$124.6M. Across 5 filings, Empyrean Capital Partners, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,925,000 shares valued at US$118.9M. Notable position changes include a 132% increase in Q3 2025 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 950.00K | $44.96M | New |
| Q3 2025 | 2.20M | $116.78M | Add |
| Q4 2025 | 2.20M | $124.56M | Hold |
| Q1 2026 | 1.93M | $112.55M | Reduce |
| Q2 2026 | 1.93M | $118.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BTI and 13F data
BTI (BRITISH AMERN TOB PLC) is a Health Care company. 33 other funds we track also report a position in BTI — the largest reported positions include Capital International Investors (US$3.04B), GQG Partners LLC (US$1.52B), Orbis Allan Gray Ltd (US$456.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BTI
- Capital International Investors 49.13M sh · $3.04B · Q2 2026
- GQG Partners LLC 24.57M sh · $1.52B · Q2 2026
- Orbis Allan Gray Ltd 7.39M sh · $456.12M · Q2 2026
- Mondrian Investment Partners LTD 4.36M sh · $237.05M · Q3 2026
- Marshall Wace 3.27M sh · $202.01M · Q2 2026
- Newport Trust Company, LLC 2.48M sh · $153.47M · Q2 2026
- Cullen Capital Management, LLC 2.18M sh · $134.37M · Q2 2026
- Maple Rock Capital Partners Inc. 2.17M sh · $133.77M · Q2 2026
- Capital International, Inc./CA/ 1.58M sh · $97.48M · Q2 2026
More on Empyrean Capital Partners, LP
FAQ
How long has Empyrean Capital Partners, LP held BTI?
Empyrean Capital Partners, LP has disclosed BTI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Empyrean Capital Partners, LP's current position in BTI?
As of Q2 2026, Empyrean Capital Partners, LP holds 1.93M shares of BTI (BRITISH AMERN TOB PLC), valued at $118.89M, representing 3.93% of its reported portfolio and ranking #3.
Has Empyrean Capital Partners, LP been buying or selling BTI?
In the latest 13F filing (Q2 2026), Empyrean Capital Partners, LP held unchanged its position in BTI. The position peaked in Q4 2025 at 2.20M shares.
Which other funds hold BTI?
Other major institutional holders of BTI include Capital International Investors, GQG Partners LLC, Orbis Allan Gray Ltd, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.